Mach7 Technologies Limited

ASX:M7T Stock Report

Market Cap: AU$68.2m

Mach7 Technologies Future Growth

Future criteria checks 1/6

Mach7 Technologies is forecast to grow earnings and revenue by 22% and 7.7% per annum respectively. EPS is expected to grow by 20.1% per annum. Return on equity is forecast to be -23.8% in 3 years.

Key information

22.0%

Earnings growth rate

20.13%

EPS growth rate

Healthcare Services earnings growth4.0%
Revenue growth rate7.7%
Future return on equity-23.76%
Analyst coverage

Low

Last updated10 May 2026

Recent future growth updates

Recent updates

Narrative Update Jun 26

M7T: Enterprise Imaging Pipeline Will Drive Future Upside Despite Near-Term Revenue Headwinds

Analysts have adjusted their price target for Mach7 Technologies to reflect an updated fair value of A$0.44, along with revised assumptions for revenue growth, profit margins, and future P/E, contributing to a recalibrated outlook for the stock. What's in the News for Mach7 Technologies Mach7 Technologies plans to showcase its enterprise imaging solutions at the SIIM26 Annual Meeting + InformaticsTECH Expo in Pittsburgh in June 2026.
Analysis Article Feb 12

Mach7 Technologies Limited (ASX:M7T) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough

The Mach7 Technologies Limited ( ASX:M7T ) share price has softened a substantial 38% over the previous 30 days...
Analysis Article Feb 05

Companies Like Mach7 Technologies (ASX:M7T) Can Afford To Invest In Growth

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Analysis Article Dec 29

Mach7 Technologies Limited (ASX:M7T) Shares Fly 27% But Investors Aren't Buying For Growth

Despite an already strong run, Mach7 Technologies Limited ( ASX:M7T ) shares have been powering on, with a gain of 27...
Analysis Article Nov 13

Improved Revenues Required Before Mach7 Technologies Limited (ASX:M7T) Shares Find Their Feet

Mach7 Technologies Limited's ( ASX:M7T ) price-to-sales (or "P/S") ratio of 2.3x might make it look like a strong buy...
Analysis Article Jul 21

Mach7 Technologies Limited (ASX:M7T) Looks Inexpensive But Perhaps Not Attractive Enough

With a price-to-sales (or "P/S") ratio of 2.9x Mach7 Technologies Limited ( ASX:M7T ) may be sending very bullish...
Analysis Article Apr 06

Revenues Working Against Mach7 Technologies Limited's (ASX:M7T) Share Price Following 27% Dive

Mach7 Technologies Limited ( ASX:M7T ) shares have had a horrible month, losing 27% after a relatively good period...
Analysis Article Mar 13

We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Analysis Article Feb 19

Mach7 Technologies Limited (ASX:M7T) Held Back By Insufficient Growth Even After Shares Climb 32%

Mach7 Technologies Limited ( ASX:M7T ) shares have had a really impressive month, gaining 32% after a shaky period...
Analysis Article Nov 06

Little Excitement Around Mach7 Technologies Limited's (ASX:M7T) Revenues As Shares Take 29% Pounding

The Mach7 Technologies Limited ( ASX:M7T ) share price has fared very poorly over the last month, falling by a...
Analysis Article Aug 30

Mach7 Technologies Limited (ASX:M7T) Just Reported And Analysts Have Been Cutting Their Estimates

Shareholders might have noticed that Mach7 Technologies Limited ( ASX:M7T ) filed its annual result this time last...
Analysis Article Aug 01

Investors Interested In Mach7 Technologies Limited's (ASX:M7T) Revenues

With a median price-to-sales (or "P/S") ratio of close to 5.6x in the Healthcare Services industry in Australia, you...
Analysis Article Jan 29

Mach7 Technologies Limited (ASX:M7T) Analysts Are More Bearish Than They Used To Be

Today is shaping up negative for Mach7 Technologies Limited ( ASX:M7T ) shareholders, with the analysts delivering a...
Analysis Article Nov 23

Mach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Analysis Article Sep 29

Is Now The Time To Look At Buying Mach7 Technologies Limited (ASX:M7T)?

While Mach7 Technologies Limited ( ASX:M7T ) might not be the most widely known stock at the moment, it received a lot...
Analysis Article Sep 04

Estimating The Fair Value Of Mach7 Technologies Limited (ASX:M7T)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Mach7 Technologies fair value estimate is AU$0.74 Mach7...
Analysis Article Jun 13

Why Mach7 Technologies Limited (ASX:M7T) Could Be Worth Watching

While Mach7 Technologies Limited ( ASX:M7T ) might not be the most widely known stock at the moment, it saw a decent...
Analysis Article Apr 28

We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Analysis Article Oct 24

An Intrinsic Calculation For Mach7 Technologies Limited (ASX:M7T) Suggests It's 47% Undervalued

Today we will run through one way of estimating the intrinsic value of Mach7 Technologies Limited ( ASX:M7T ) by taking...
Analysis Article Jun 23

Are Investors Undervaluing Mach7 Technologies Limited (ASX:M7T) By 37%?

Does the June share price for Mach7 Technologies Limited ( ASX:M7T ) reflect what it's really worth? Today, we will...
Analysis Article May 19

Is Mach7 Technologies Limited (ASX:M7T) Potentially Undervalued?

While Mach7 Technologies Limited ( ASX:M7T ) might not be the most widely known stock at the moment, it saw a...

Earnings and Revenue Growth Forecasts

ASX:M7T - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202937N/AN/AN/A1
6/30/202834-5-2-12
6/30/202730-8-5-32
6/30/202628-10-7-42
12/31/202530-10-10N/A
9/30/202532-8-10N/A
6/30/202534-6-11N/A
3/31/202534-6-11N/A
12/31/202434-501N/A
9/30/202431-712N/A
6/30/202429-833N/A
3/31/202428-733N/A
12/31/202327-622N/A
9/30/202329-300N/A
6/30/202330-1-3-3N/A
3/31/202329-2-2-1N/A
12/31/202228-400N/A
9/30/202227-433N/A
6/30/202226-466N/A
3/31/202226-356N/A
12/31/202126-355N/A
9/30/202123-633N/A
6/30/202119-911N/A
3/31/202118-911N/A
12/31/202017-800N/A
9/30/202018-423N/A
6/30/202019055N/A
3/31/202017-133N/A
12/31/201915-211N/A
9/30/201912-5N/A-1N/A
6/30/20199-7N/A-3N/A
3/31/20199-7N/A-4N/A
12/31/20188-6N/A-4N/A
9/30/20188-5N/A-3N/A
6/30/20189-5N/A-2N/A
3/31/20189-11N/A-2N/A
12/31/20179-17N/A-3N/A
9/30/201710-17N/A-4N/A
6/30/201710-18N/A-5N/A
3/31/20178-16N/A-5N/A
12/31/20166-15N/A-4N/A
9/30/20164-14N/A-4N/A
6/30/20162-13N/A-3N/A
12/31/20158-3N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: M7T is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: M7T is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: M7T is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: M7T's revenue (7.7% per year) is forecast to grow faster than the Australian market (6% per year).

High Growth Revenue: M7T's revenue (7.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: M7T is forecast to be unprofitable in 3 years.


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/02 09:42
End of Day Share Price 2026/07/02 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mach7 Technologies Limited is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madeleine WilliamsCanaccord Genuity
Shane StoreyCanaccord Genuity
Scott PowerCGS International